A new route to vaccines using PROTACs - Nature Biotechnology

Argentina Noticias Noticias

A new route to vaccines using PROTACs - Nature Biotechnology
Argentina Últimas Noticias,Argentina Titulares
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 63%

An influenza vaccine is created by attenuating the live virus through targeted proteolysis NBTNV

Influenza has been overshadowed by the COVID-19 pandemic, but it remains a major threat to global health. Improved vaccines that deploy innovative technologies will be welcome additions to our options for the control of influenza. In a novel application of targeted degradation published in. describe the development of proteolysis-targeting chimeric influenza vaccines.

Despite their clinical efficacy and widespread uptake, influenza vaccines have well-known limitations. Influenza viruses undergo antigenic drift — a gradual accumulation of point mutations due to error-prone replication; mutations in the surface glycoproteins hemagglutinin and neuraminidase can generate variants that evade immunity induced by prior infection or vaccination.

Current seasonal influenza vaccines induce strain-specific immunity and generally lack efficacy against variants that have undergone antigenic drift or shift. Improved vaccines that can elicit broader and more durable immunity are a public health priority, and many next-generation influenza vaccines are in development.

PROTACs are bifunctional molecules that induce the degradation of a protein of interest by targeting it to the ubiquitin–proteasome system

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

NatureBiotech /  🏆 231. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

The digital phenotype of vaccination - Nature BiotechnologyThe digital phenotype of vaccination - Nature BiotechnologyNature Biotechnology - The digital phenotype of vaccination
Leer más »

Precision cancer targeting with antibody pairs - Nature BiotechnologyPrecision cancer targeting with antibody pairs - Nature BiotechnologyLogic-gated monoclonal antibodies have been designed to improve safety and efficacy NBTNV
Leer más »

Walters: California taxpayers will subsidize new A’s ballparkWalters: California taxpayers will subsidize new A’s ballparkThe $279.5 million may not technically be a gift of public funds to a private developer, but it certainly smells like one.
Leer más »

New Omicron COVID Boosters Coming Soon: What to Know NowNew Omicron COVID Boosters Coming Soon: What to Know NowNew COVID-19 vaccine boosters, targeting new Omicron strains of the virus, are expected to roll out across the U.S. in September – a month ahead of schedule, the Biden administration announced this week.
Leer más »

White House Declares Monkeypox a Public Health EmergencyWhite House Declares Monkeypox a Public Health EmergencyBREAKING: The White House has declared monkeypox a public health emergency. There have been over 6,600 reported cases of monkeypox in the United States, up from the under 5,000 cases reported last week.
Leer más »

New Breast Cancer Treatments Inspired by mRNA COVID-19 Vaccine InnovationNew Breast Cancer Treatments Inspired by mRNA COVID-19 Vaccine InnovationScientists at Queen’s University Belfast have received funding from Breast Cancer Now to support their quest for new treatments inspired by COVID-19 vaccine innovation. The research team will adapt lessons from the development of COVID-19 vaccines in the search for new treatments for an aggressive f
Leer más »



Render Time: 2025-03-14 19:24:03